Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Thymus Serpyllum, commonly known as Wild Thyme, is primarily utilized as a non-standardized food and plant allergenic extract for the diagnosis and treatment of IgE-mediated allergic sensitivities.
Name
Thymus Serpyllum
Raw Name
THYMUS SERPYLLUM
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
8
Variant Count
8
Last Verified
February 17, 2026
About Thymus Serpyllum
Thymus Serpyllum, commonly known as Wild Thyme, is primarily utilized as a non-standardized food and plant allergenic extract for the diagnosis and treatment of IgE-mediated allergic sensitivities.
Detailed information about Thymus Serpyllum
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Thymus Serpyllum.
Historically, the FDA has regulated allergenic extracts under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act. Thymus Serpyllum belongs to a class of diagnostic and therapeutic biologicals intended to identify or desensitize individuals who exhibit allergic reactions to members of the Lamiaceae family. While Thyme is commonly used as a culinary herb, individuals may develop systemic or localized allergic reactions upon ingestion or inhalation of its pollen or volatile oils. The extract is typically prepared from the dried leaves and flowering tops of the plant, containing a complex mixture of proteins, glycoproteins, and polysaccharides that serve as the allergenic determinants.
At the molecular level, Thymus Serpyllum extract functions as an antigen (a substance that triggers an immune response). In patients who are sensitized to Thyme, their immune system has produced specific Immunoglobulin E (IgE) antibodies that recognize the proteins within the Thymus Serpyllum extract. When the extract is introduced into the body—either through a skin prick test (SPT) or an intradermal injection—these IgE antibodies, which are bound to the surface of mast cells (immune cells in the tissue) and basophils (immune cells in the blood), cross-link with the allergen.
This cross-linking triggers a process called degranulation, where the mast cells release inflammatory mediators, most notably histamine, leukotrienes, and prostaglandins. In a diagnostic setting, this results in a 'wheal and flare' reaction (a raised bump surrounded by redness) within 15 to 20 minutes, confirming the patient's sensitivity. In the context of immunotherapy, repeated, escalating doses of the extract are administered to shift the immune response from a Th2-cell mediated allergic response to a Th1-cell or T-regulatory (Treg) cell response. This process, known as desensitization, involves the production of 'blocking antibodies' (IgG4) that prevent the allergen from binding to IgE, thereby reducing the severity of allergic symptoms over time.
The pharmacokinetic study of allergenic extracts differs significantly from traditional small-molecule drugs. Because these are complex biological mixtures administered locally, traditional metrics like 'half-life' or 'CYP450 metabolism' are not applicable in the standard sense.
Thymus Serpyllum extracts are primarily used for the following indications:
Thymus Serpyllum is typically available in the following formats for clinical use:
> Important: Only your healthcare provider can determine if Thymus Serpyllum is right for your specific condition. The use of allergenic extracts must be conducted under the supervision of a clinician trained in the management of systemic allergic reactions.
Dosage for Thymus Serpyllum allergenic extract is highly individualized and depends entirely on whether the extract is being used for diagnostic purposes or therapeutic immunotherapy. There is no 'standard' dose, as the concentration is determined by the patient's level of sensitivity.
For the initial evaluation, a single drop of the 1:10 or 1:20 w/v (weight/volume) solution is applied to the skin (usually the forearm or back). A sterile lancet is then used to prick the skin through the drop. A positive control (histamine) and a negative control (saline) are always used simultaneously for comparison.
If used for desensitization, the 'build-up phase' typically begins with a very low dose, such as 0.05 mL of a 1:10,000 w/v dilution. Doses are increased weekly or bi-weekly by 0.05 mL to 0.1 mL increments until a 'maintenance dose' is reached (often 0.5 mL of a 1:10 or 1:20 w/v solution). The maintenance dose is then administered every 2 to 4 weeks for a period of 3 to 5 years.
Thymus Serpyllum extracts can be used in children, but extreme caution is required.
No specific dosage adjustments are required for patients with kidney disease, as the extract is not cleared through traditional renal pathways. However, the patient's overall health must be stable before administration.
No dosage adjustments are necessary for patients with liver disease. The metabolic breakdown of proteins occurs primarily at the site of injection and via the lymphatic system.
Older adults may have reduced skin reactivity, leading to potential false-negative results in skin testing. Furthermore, elderly patients are at higher risk if a systemic reaction occurs, particularly if they have underlying cardiovascular disease. Healthcare providers may use more conservative dosing increments during the build-up phase of immunotherapy.
Thymus Serpyllum allergenic extract is never self-administered by the patient at home. It must be administered in a clinical setting (doctor's office or infusion center) equipped with emergency resuscitation equipment, including oxygen, IV fluids, and epinephrine (adrenaline).
In immunotherapy, consistency is critical. If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated to maintain safety. If several weeks are missed during the maintenance phase, the clinician will typically 'back-track' to a safer, lower concentration and rebuild the dose. You should never attempt to 'double up' on doses to make up for a missed appointment.
An 'overdose' in the context of allergenic extracts refers to the administration of a concentration higher than the patient's current tolerance level. Signs of an overdose are synonymous with a systemic allergic reaction and may include:
In the event of an overdose/systemic reaction, emergency protocols are initiated immediately, typically involving the injection of epinephrine and transfer to an emergency department.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Side effects associated with Thymus Serpyllum are primarily localized to the site of administration. These are expected reactions and indicate that the immune system is interacting with the allergen.
> Warning: Stop taking Thymus Serpyllum and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Thymus Serpyllum allergenic extract on organs like the liver, kidneys, or brain. The primary long-term risk is the development of increased sensitivity if the immunotherapy is not managed correctly. However, for most patients, the long-term effect is a beneficial reduction in allergic symptoms and a decreased risk of developing asthma.
Allergenic extracts, including Thymus Serpyllum, carry a class-wide FDA Black Box Warning regarding the risk of severe systemic reactions.
Summary of Warning:
Report any unusual symptoms to your healthcare provider. Even a mild systemic reaction (like a few hives) must be reported, as it may predict a more severe reaction with the next dose.
Thymus Serpyllum allergenic extract is a potent biological product. Its safety depends entirely on proper administration, accurate dilution, and vigilant patient monitoring. It is not a conventional medication and should never be used for self-treatment of symptoms. Patients must be informed that the goal of the extract is to elicit an immune response, which inherently carries the risk of an overreaction.
No FDA black box warnings for Thymus Serpyllum specifically exist as an individual drug, but it falls under the General Black Box Warning for Allergenic Extracts. This warning emphasizes that these products can cause anaphylaxis, which may be fatal. The warning mandates that the extract be administered only in settings where emergency resuscitation is available and that patients must be monitored for a minimum of 30 minutes post-injection.
Most patients can drive after the 30-minute observation period. However, if a patient experiences dizziness, fatigue, or receives antihistamines/epinephrine for a reaction, they should not drive or operate heavy machinery until symptoms have fully resolved and they are cleared by a physician.
There is no direct chemical interaction between alcohol and Thymus Serpyllum extract. However, alcohol consumption can cause vasodilation (widening of blood vessels), which may theoretically increase the rate of allergen absorption and the severity of a systemic reaction. It is generally advised to avoid alcohol for several hours before and after an injection.
Immunotherapy can be discontinued at any time, but doing so will result in the gradual return of allergic sensitivity. There is no 'withdrawal syndrome' associated with stopping allergenic extracts, but the therapeutic benefits (desensitization) will be lost if the 3-to-5-year course is not completed.
> Important: Discuss all your medical conditions with your healthcare provider before starting Thymus Serpyllum.
For each major interaction, the mechanism usually involves either the masking of symptoms (antihistamines) or the interference with emergency treatment (beta-blockers). The clinical consequence of the latter is a significantly increased risk of mortality during an adverse event. The primary management strategy is to switch the patient to an alternative class of medication (e.g., switching from a beta-blocker to a calcium channel blocker) before starting Thymus Serpyllum treatment.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Thymus Serpyllum allergenic extract must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by a specialist:
Patients should be aware of 'Oral Allergy Syndrome' or cross-reactivity. If you are allergic to Thymus Serpyllum, you may also be sensitive to:
If you have had a severe reaction to any of these herbs, you must inform your doctor before undergoing testing with Thymus Serpyllum.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Thymus Serpyllum.
Thymus Serpyllum is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk to the fetus is not the extract itself, but the potential for maternal anaphylaxis. A severe drop in maternal blood pressure or respiratory failure can lead to fetal distress, miscarriage, or premature labor.
It is not known whether the components of Thymus Serpyllum extract are excreted in human milk. However, since the allergens are large proteins that are broken down locally, it is highly unlikely that they would reach the breast milk in any significant or harmful quantity. Breastfeeding is generally considered safe for women receiving allergenic extracts, provided they are monitored for reactions.
In patients over 65, the risk-benefit ratio must be carefully weighed. Older adults are more likely to have underlying cardiovascular or pulmonary diseases that make them 'brittle' in the event of an allergic reaction. Additionally, polypharmacy (taking multiple medications) increases the likelihood of drug interactions with beta-blockers or ACE inhibitors. Skin testing may be less accurate in this population due to age-related changes in skin turgor and mast cell density.
There are no specific guidelines for renal impairment. Because the extract is a biological protein mixture, it does not undergo renal filtration in the way a chemical drug does. However, patients with end-stage renal disease (ESRD) may have altered immune function and should be treated with caution.
No dosage adjustments are required. The liver is not the primary site of metabolism for injected allergenic proteins.
> Important: Special populations require individualized medical assessment. Always inform your specialist about your full health status.
Thymus Serpyllum extract acts as a source of exogenous allergens. The primary allergens in Thyme are proteins and glycoproteins.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Local/Subcutaneous) |
| Protein Binding | Primarily to IgE and IgG4 |
| Half-life | Minutes to hours (Proteolysis) |
| Tmax | 15–30 minutes (Local reaction) |
| Metabolism | Local Proteolysis |
| Excretion | Lymphatic clearance |
Thymus Serpyllum is classified as a Non-Standardized Allergenic Extract. It belongs to the broader therapeutic category of Biologicals / Immunotherapy Agents. Related medications include other Lamiaceae extracts (like Oregano or Mint) and standardized extracts like Ragweed or Timothy Grass.
Common questions about Thymus Serpyllum
Thymus Serpyllum, or Wild Thyme extract, is primarily used by allergy specialists to diagnose and treat allergic sensitivities. In a diagnostic setting, it is used in skin prick tests to confirm if a patient has an IgE-mediated allergy to Thyme or related herbs. Therapeutically, it is used in allergen immunotherapy (allergy shots) to help desensitize the patient's immune system over time. This process involves giving gradually increasing doses of the extract to reduce the severity of allergic reactions upon future exposure. It is particularly useful for individuals with occupational exposure or severe food allergies to the Lamiaceae plant family.
The most frequent side effects are localized to the site where the extract was applied or injected. These include itching, redness, and a raised bump known as a 'wheal,' which are normal parts of the diagnostic process. In patients receiving allergy shots, swelling and tenderness at the injection site are common and can last for a day or two. Some patients may also experience mild systemic symptoms like sneezing, congestion, or a slight headache. While these are usually not dangerous, they must be reported to the healthcare provider before the next dose is administered.
It is generally recommended to avoid alcohol for several hours before and after receiving a Thymus Serpyllum injection. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of the allergen into your bloodstream and potentially increase the risk or severity of a systemic allergic reaction. Furthermore, alcohol can mask some of the early warning signs of anaphylaxis, such as feeling flushed or dizzy. To ensure maximum safety during the observation period and the hours following your treatment, it is best to remain sober. Always discuss your lifestyle habits with your allergist.
Thymus Serpyllum is generally not started as a new treatment during pregnancy because of the risk of a severe allergic reaction (anaphylaxis). While the extract itself does not directly harm the fetus, a major allergic reaction in the mother can cause a dangerous drop in oxygen and blood pressure for the baby. If a patient is already on a stable maintenance dose of immunotherapy and is tolerating it well, many doctors will allow them to continue the treatment, but they will not increase the dose. Skin testing for diagnostic purposes is usually postponed until after delivery. Always consult your obstetrician and allergist if you become pregnant.
For diagnostic purposes, Thymus Serpyllum works very quickly, with results appearing on the skin within 15 to 20 minutes. However, if you are undergoing immunotherapy (allergy shots) for desensitization, the process is much slower. Most patients do not notice a significant decrease in their allergic symptoms until they reach their 'maintenance dose,' which typically takes 3 to 6 months of weekly injections. Full effectiveness and long-term protection usually require a committed treatment plan lasting 3 to 5 years. Patience and consistency are key to the success of this treatment.
Yes, you can stop receiving Thymus Serpyllum injections at any time without experiencing physical withdrawal symptoms like those seen with some medications. However, stopping the treatment before the recommended 3-to-5-year course is complete will likely result in your allergies returning to their original severity. The 'tolerance' your immune system has built up will gradually fade away. If you need to stop treatment due to side effects, financial reasons, or a move, you should discuss a tapering or transition plan with your allergist to see if any of the progress you've made can be maintained.
If you miss an appointment for your Thymus Serpyllum immunotherapy, you should contact your allergy clinic as soon as possible to reschedule. Do not try to make up for the missed dose by taking a higher dose later. Depending on how many weeks have passed since your last injection, your doctor may need to repeat your previous dose or even reduce the dose slightly to ensure your safety. Missing too many doses can set your treatment progress back significantly, as the immune system needs regular exposure to the allergen to maintain its desensitized state.
There is no clinical evidence to suggest that Thymus Serpyllum allergenic extract causes weight gain. The extract consists of a very small amount of protein and does not contain calories or hormones that would affect your metabolism or appetite. If you notice weight changes while undergoing immunotherapy, it is likely due to other factors, such as lifestyle changes, other medications (like oral steroids sometimes used for allergy flares), or an unrelated medical condition. You should discuss any significant weight changes with your primary care physician.
Thymus Serpyllum can interact with several types of medications, some of which are very serious. The most critical interaction is with beta-blockers, which can make life-saving epinephrine ineffective during an emergency. Other medications, like antihistamines, must be stopped before skin testing because they can cause false-negative results. ACE inhibitors and certain antidepressants may also increase the risks associated with a systemic reaction. It is vital that you provide your allergist with a complete and updated list of all prescription and over-the-counter medications you are taking.
The concept of 'generic' vs. 'brand name' works differently for allergenic extracts. Thymus Serpyllum is a biological product produced by several different specialized laboratories (such as Greer, ALK, or HollisterStier). While the extracts are essentially the same plant material, they are 'non-standardized,' meaning the exact potency can vary slightly between manufacturers. Because of this, allergists generally prefer not to switch between different manufacturers' extracts once a patient has started a treatment course. It is not available as a standard 'generic' pill at a local pharmacy.